Periostin: a novel biomarker for chronic rhinosinusitis.

CONCLUSION: Periostin can be used as a novel biomarker for chronic rhinosinusitis, which provides a potential target for individualized therapy of chronic rhinosinusitis. PMID: 29709135 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29709135?dopt=Abstract

Source: B-ENT - May 3, 2018 Category: ENT & OMF Tags: B-ENT Source Type: research

More News: ENT & OMF | Polyps | Study